US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Starling Oncology, Inc. - Common Stock (NQ:STLN)

6.350 +0.130 (+2.09%)
Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Starling Oncology, Inc. - Common Stock

News headline image
Starling Oncology Leadership Highlights Recent and Upcoming Industry Conference Participation
Physician leaders share clinical insights on value-based therapy delivery, clinical trial access and integrated behavioral health in community oncology at major industry forums 
From Starling Oncology
Via GlobeNewswire
News headline image
Starling Oncology to Participate in Wells Fargo Healthcare Conference
From Starling Oncology
Via GlobeNewswire
News headline image
Starling Oncology Launches Starling Nexus™, a Technology Platform Built to Optimize Oncology Provider Engagement and Accelerate High-Quality Care at Scale
Company’s proprietary platform brings clinical decision support and evidence-based pathways into one streamlined oncology workflow 
From Starling Oncology
Via GlobeNewswire
News headline image
Starling Oncology Reports Second Quarter 2026 Financial Results and Updates Full-Year 2026 Guidance
From Starling Oncology
Via GlobeNewswire